Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Schedule: Weekly subcutaneous injections for 1620+ weeks with gradual dose escalation
The sensitivity of lipid profiles in reflecting RA activity and response to disease-modifying anti/rheumatic drugs (DMARDs) (191)
Severe, persistent upper abdominal pain that radiates to the back, accompanied by nausea, vomiting, and fever, are key warning signs
CD3 BUV508 (eBioscience, clone 17A2, 368-0032-82, 1:300)
US$ 26.85
US$ 21.32
US$ 26.48
US$ 25.09
